Lichen planus and leukocytoclastic vasculitis induced by interferon alpha-2b in a subject with HCV-related chronic active hepatitis

Journal of the European Academy of Dermatology and Venereology

Volumn 17, Issue 2, 2003, Pages 193-195

  de Sousa Pinto, Jorge M ^a   Sacramento Marques, M ^a   Estanislau Correia, T ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Chronic active hepatitis; IFN ; Leukocytoclastic vasculitis; Lichen planus

Indexed keywords

MOMETASONE FUROATE; RECOMBINANT ALPHA2B INTERFERON;

ADULT; ARTICLE; CASE REPORT; CHRONIC LIVER DISEASE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG WITHDRAWAL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; LEUKOCYTOCLASTIC VASCULITIS; LICHEN PLANUS; LYMPHOPROLIFERATIVE DISEASE; MELANOMA; PAPULE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PRURITUS; SKIN EXAMINATION; SKIN PIGMENTATION;

ANTIVIRAL AGENTS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; LICHEN PLANUS; MIDDLE AGED; VASCULITIS, HYPERSENSITIVITY;

EID: 0037359180     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2003.00583.x     Document Type: Article

References (24)

1. Rebora A, Rongioletti F. Lichen planus and chronic active hepatitis. A retrospective survey. Acta Derm Venereol (Stockh) 1984; 64: 52-56.
2. Graham-Brown RAC, Sarkany I, Sherlock S. Lichen planus and primary biliary cirrhosis. Br J Dermatol 1982; 106: 699-703.
3. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED). Lichen planus and liver diseases: a multicentre case-control study. Br Med J 1990; 300: 227-230.
4. Robert E, Rongioletti F, Rebora A. Clinical and laboratory features of 50 patients with lichen planus and a chronic liver disease. G Ital Dermatol Venereol 1991; 126: 1-4.
5. Ciaccio M, Rebora A. Lichen planus following HBV vaccination: a coincidence? Br J Dermatol 1990; 122:424.
6. Trevisan G, Stinco G. Lichen ruber planus following HBV vaccination. Acta Derm Venereol (Stockh) 1993; 73: 73.
7. Aubin F, Angonin R, Humbert P, Agache P. Lichen planus following hepatitis B vaccination. Arch Dermatol 1994; 130: 1329-1330.
8. Strumia R, Venturini D, Boccia S, Gamberini S, Gullini S. UVA and interferon-alfa therapy in a patient with lichen planus and chronic hepatitis C. Int J Dermatol 1993; 32: 386.
9. Protzer U, Ochsendorf FR, Leopolder-Ochsendorf A, Holtermuller K-H. Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C. Gastroenterology 1993; 104: 903-905.
10. D'Agay-Abensour L, Benamouzig R, Belilovsky C et al. Lichen plan au cours d'une hépatite chronique C traitée par interféron alpha. Gastroenterol Clin Biol 1992; 16: 610-611.
11. Papini M, Bruni PL, Bettacchi A, Liberati F. Sudden onset of oral ulcerative lichen in a patient with chronic hepatitis C on treatment with alfa-interferon. Int J Dermatol 1994; 33: 221-222.
12. Rodrigues B, Oliveira M, Inock A. Lichen plan induit par l'interféron 2b chez un malade avec un myélome IgG. Nouv Dermatol 1989; 8: 29-31.
13. Aubin F, Bouzerane Y, Blanc D et al. Severe lichen planus-like eruption induced by interferon alpha therapy. Eur J Dermatol 1995; 5: 296-299.
14. Kutting B, Bohm M, Luger TA, Bonsmman G. Oropharyngeal lichen planus associated with interferon-α treatment for mycosis fungoides: a rare side-effect in the therapy of cutaneous lymphomas. Br J Dermatol 1997; 137: 836-837.
15. Saval AH, Martinez FC. Lichen planus induced by interferon-α-2b therapy in a patient with cutaneous malignant melanoma. Acta Derm Venereol 1999; 79: 395.
16. Antonelli G, Currenti M, Turriziani O, Dianzani F. Neutralizing antibodies to interferon-a: relative frequency in patients with different interferon preparations. J Infect Dis 1991; 163: 882-885.
17. Detmar U, Agathos M, Nerl C. Allergy of delayed type to recombinant interferon α 2c. Contact Dermatitis 1989; 20: 149-150.
18. Bonetti P, Diodati G, Drago C et al. Interferon antibodies in patients with chronic hepatitic C virus infection treated with recombinant interferon alpha-2α. J Hepatol 1994; 20: 416-420.
19. Matikainen S, Sareneva T, Ronni T et al. Interferon-α activates multiple STAT proteins and upregulates proliferation-associated IL-2Rα, c-myc, and pim-1 genes in human T cells. Blood 1999; 93: 1980-1991.
20. Marrack P, Kappler J, Mitchell T. Type I interferons keep activated T cells alive. J Exp Med 1999; 189: 521-529.
21. Rogge L, Barberis-Maino L, Biffi M et al. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 1997; 185: 825-831.
22. Manetti R, Annunziato F, Tomasevic L et al. Polyinosinic acid: Polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon alpha and interleukin-12. Eur J Immunol 1995; 25: 2656-2660.
23. Sareneva T, Matikainen S, Kurimoto M, Julkunen I. Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gama gene expression in human T cells. J Immunol 1998; 160: 6032-6038.
24. Nickollof BJ, Lewinsohn DM, Butcher EC, Krensky AM, Clayberger C. Recombinant gamma interferon increases the binding of peripheral blood mononuclear leukocytes to a malignant cutaneous squamous cell carcinoma cell line that is blocked by antibody against the LFA-1 molecule. J Invest Dermatol 1988; 90: 17-22.